The Glaucoma Research Foundation (GRF) announced an unprecedented $2.5 million allocation in annual ...
read moreOcuTerra Therapeutics' phase 2 trial for nesvategrast, an eye drop for diabetic retinopathy, failed ...
read morePandorum Technologies, a pioneering startup in the field of Tissue Engineering and Regenerative Medi...
read moreMediPrint Ophthalmics has successfully completed its SIGHT-2 phase 2b study, showcasing the efficacy...
read moreFormycon AG and MS Pharma announced that their product, Ravegza (FYB201), a biosimilar to Lucentis (...
read moreRegeneron Pharmaceuticals announced that The Lancet has published the one-year results of the pivota...
read moreStatistics & Data Corporation (SDC) has made a pivotal decision to hand over its ophthalmic biometri...
read moreVital Tears, known for its innovative autologous serum tears, is excited to announce the appointment...
read moreTelios Pharma, Inc. announced promising topline results from its Phase 2 study of TL-925, a pioneeri...
read moreRoche Pharma India Ltd. has launched Vabysmo (faricimab) for the treatment of age-related macular de...
read more